Growing trend of personalized medicine is a key factor projected to support growth of proteomics market.
New York, NY -- (SBWIRE) -- 04/23/2021 -- The global Proteomics Market is expected to reach a market size of USD 57.57 Billion by 2027 and register a high CAGR during the forecast period, according to a new report by Reports and Data.
The proteomics market is witnessing increased revenue growth due to the growing popularity of personalized medicines, advancements in technology, and rise in research & development expenditure and initiatives. A key driving factor is the rising trend of personalized medicine. Biotechnology and pharmaceutical companies have over the years doubled their investment in R&D of personalized medicine. Advancement in proteomics technologies contributed to the development of personalized medicines by enabling detection of proteomics molecular diagnostics, protein biomarkers, pharmacoproteomics, and protein biochips. Personalized medicine is commonly used in cancer treatment.
High cost of proteomics equipment and lack of skilled workforce is a factor hampering growth of the market. However, growth in biomarker identification and advancements in mass spectrometry-based proteomics are expected to provide growth opportunities in the proteomics market. Development of efficient and advanced technologies, rise in genetic and birth disorders, increasing healthcare expenditure, and availability of funds from both public and private sectors will contribute significantly to growth of the market.
Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/3769
Further key findings in the report
The reagent segment among the product segments accounted for the largest revenue share in 2019. Increasing research activities and growing need for protein separation from complex mixtures for effective analysis is expected to continue to drive revenue growth of this segment.
Microarray segment dominated other technology segments in terms of revenue share in 2019. Microarray offers label-free detection, full imprint of proteins, and produces vast amounts of information from small samples, which is driving demand for application in biopharmaceutical companies.
The drug discovery segment revenue is expected to continue to register a robust growth rate due to increasing application of proteomics in identification of toxicity and efficacy from biological fluids and target validation and identification. Identification of new drugs by proteomics is one of the major factors supporting market growth.
North America accounted for the largest share in the global proteomics market in 2019. Increasing research activities in healthcare, high funding from governments, and rising need for improved healthcare infrastructure are some key factors driving growth of the market.
Key participants include Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck KgaA, PerkinElmer, Inc., Promega Corporation, Waters Corporation, Bruker Corporation, and GE Healthcare.
Browse Complete Report "Proteomics Market" @ https://www.reportsanddata.com/report-detail/proteomics-market
For the purpose of this report, Reports and Data has segmented the global proteomics market on the basis of product, technology, application, and region:
Product Outlook (Revenue, USD Billion; 2017-2027)
Instruments
Reagents
Services
Technology Outlook (Revenue, USD Billion; 2017-2027)
X-Ray Crystallography
Chromatography
Microarray Instruments
Protein Fractionation Systems
Surface Plasma Resonance (SPR) Systems
Electrophoresis
Spectroscopy
Application Outlook (Revenue, USD Billion; 2017-2027)
Clinical Diagnosis
Drug Discovery
Others
Regional Outlook (Revenue in USD Billion; 2017–2027)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
TOC -
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Proteomics Market Segmentation & Impact Analysis
4.1. Proteomics Market Material Segmentation Analysis
4.2. Industrial Outlook
…………..
Chapter 9. Competitive Landscape
9.1. Market Revenue Share By Manufacturers
9.2. Manufacturing Cost Breakdown Analysis
9.3. Mergers & Acquisitions
9.4. Market positioning
9.5. Strategy Benchmarking
9.6. Vendor Landscape
Chapter 10. Company Profiles
10.1. Agilent Technologies, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Technology Insights
10.1.4. Strategic Initiatives
10.2. Danaher Corporation
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Technology Insights
10.2.4. Strategic Initiatives
10.3. Bio-Rad Laboratories, Inc.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Technology Insights
10.3.4. Strategic Initiatives
10.4. Thermo Fisher Scientific, Inc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Technology Insights
10.4.4. Strategic Initiatives
10.5. Merck KgaA
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Technology Insights
10.5.4. Strategic Initiatives
Continued……….
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3769
The report is a qualitative and quantitative research study that offers key insights into the latest strategic steps and tactics undertaken by the industry players to gain a robust footing in the market. The report further offers strategic recommendations to the new and emerging players and established companies to help them overcome the barriers of the industry. The report also covers a comprehensive SWOT analysis and Porter's Five Forces analysis to offer a better understanding of the Proteomics market and its competitive landscape.
Browse Related Reports –
Refractories Market Analysis
Intravenous Immunoglobulin (IVIG) Market Trends
Stainless Steel Forging Market Growth
Genome Editing Market Demand
Foot and Mouth Disease (FMD) Vaccine Market Size
Arthroscopy Market Share
Thank you for reading our report. For further inquiries or queries about customization, please get in touch with us. Our team will ensure the report you get is best suited to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com